Birchtree Investments Announces Proposed Investment in Digital Motion Corporation

(CNSX:BRCH),(CNSX:BRCH.CN), VANCOUVER, British Columbia, Dec. 30, 2025 (GLOBE NEWSWIRE) — Birchtree Investments Ltd. (“Birchtree” or the “Company“) (CSE: BRCH), an investment company with the long-term goal of divesting its investment assets at a profit, today announces the execution of a non-binding term sheet dated December 30, 2025 (the “Term Sheet“) to acquire a 50% equity […]

ITGR Investors Have Opportunity to Lead Integer Holdings Corporation Securities Fraud Lawsuit with the Schall Law Firm

ITGR Investors Have Opportunity to Lead Integer Holdings Corporation Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire December 30, 2025 LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Integer Holdings Corporation (“Integer” or “the Company”) (NYSE:

Birchtree Investments Announces Proposed Investment in Digital Motion Corporation

Birchtree Investments Announces Proposed Investment in Digital Motion Corporation GlobeNewswire December 30, 2025 VANCOUVER, British Columbia, Dec. 30, 2025 (GLOBE NEWSWIRE) — Birchtree Investments Ltd. (“Birchtree” or the “Company“) (CSE: BRCH), an investment company with the long-term goal of divesting its investment assets at a profit, today announces the execution of a non-binding term sheet

Transaction in Own Shares

(Euronext Amsterdam:SHELL),(LSE:SHEL),(NYSE:SHEL), Transaction in Own Shares 30 December, 2025 • • • • • • • • • • • • • • • • Shell plc (the 'Company') announces that on 30 December, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of

Transaction in Own Shares

Transaction in Own Shares GlobeNewswire December 30, 2025 Transaction in Own Shares 30 December, 2025 • • • • • • • • • • • • • • • • Shell plc (the 'Company') announces that on 30 December, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased

DEADLINE ALERT for JYD, STUB, ARE, and SFM: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

(NASDAQ:JYD),(NASDAQ:SFM),(NYSE:ARE),(NYSE:STUB), LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged

DEADLINE ALERT for JYD, STUB, ARE, and SFM: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

DEADLINE ALERT for JYD, STUB, ARE, and SFM: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire December 30, 2025 LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of

DEADLINE ALERT for FUN, INSP, and TLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

(NYSE:FUN),(NYSE:INSP),(NASDAQ:TLX), LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged

DEADLINE ALERT for FUN, INSP, and TLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

DEADLINE ALERT for FUN, INSP, and TLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire December 30, 2025 LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders

Tiger BioSciences Spotlights Major Clinical and Scientific Milestones Following Significant 2025 Research Investment

Tiger BioSciences highlights a series of major clinical and scientific achievements resulting from the company's expanded investment in evidence‑based research throughout 2025. This strategic focus has strengthened Tiger BioSciences' position as a market leader heading into 2026, with a portfolio increasingly defined by data, clinical validation, and scientific evidence. https://mma.prnewswire.com/media/2823019/TigerBiosciencesCircleColor_copy_Logo.jpg In 2025, Tiger BioSciences supported

Scroll to Top